REXNYSEIndustrial Organic ChemicalsFiscal year ends January 31
REX AMERICAN RESOURCES Corp
Financials through Q2 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026
$40.45−1.27 (-3.04%)
Close on Oct 19, 2026
- Market cap
- $1.34B
- P/E (TTM)
- 11.1
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
19.3%+14.0 pts over 5 years
Net margin
–
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +1.2% | -8.7% | +11.8% | +4.1% | |
| Gross profit | +37.1% | +37.2% | +45.1% | +9.5% | |
| EPS, diluted | +51.5% | +47.1% | +98.2% | +13.3% | |
| Free cash flow | – | +8.0% | – | +7.2% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 9.9% | 0.8% | – | |
| Return on assets | 7.4% | 0.6% | – | |
| Current ratio | 10.06 | 8.42 | 5.94 | |
| Inventory turnover | 22.4× | 9.7× | 17.5× | |
| Capex to revenue | 3.1% | 2.8% | 10.5% | |
| Diluted shares | 40M | 37M | 33M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Rex American Resources generated $456.50M from operations and spent $265.89M on capital expenditure, dividends and share buybacks. 75% of that went back into the business.
Generated
$456.50M
Used
$265.89M
Capital expenditure$198.12M75%Dividends$00%Share buybacks$67.76M25%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin7.3%
×Asset turnover1.34×
×Equity multiplier1.29×
=Return on equity, FY202312.7%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2023 | 7.3% | 1.34× | 1.29× | 12.7% |
| FY2022 | 3.2% | 1.51× | 1.29× | 6.3% |
| FY2021 | 6.8% | 1.50× | 1.26× | 12.8% |
| FY2020 | 0.8% | 0.76× | 1.25× | 0.8% |
| FY2019 | 1.8% | 0.86× | 1.22× | 1.9% |
| FY2018 | 6.5% | 1.02× | 1.23× | 8.2% |
| FY2017 | 8.8% | 0.97× | 1.29× | 11.0% |
| FY2016 | 7.1% | 1.04× | 1.33× | 9.9% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
3of 5 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero–
- Cash generatingOperating cash flow above zero$117.83M
- Return on assets improvedROA up on the prior year– → –
- Earnings backed by cashOperating cash flow above net income$117.83M vs –
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose8.64 → 5.94
- No dilutionShare count did not rise35M → 33M
- Gross margin improvedGross margin up on the prior year14.24% → 19.28%
- More efficientAsset turnover rose0.97 → 0.90